Asthma is caused by a combination of factors. People who develop asthma may have a genetic predisposition and react to ...

According to national guidelines, mild persistent asthma is defined by a need for β-agonist treatment more than 2 days per week (but less than daily), asthma-related nighttime awakenings more ...

Personal asthma triggers may vary, but it’s important to identify your own and avoid exposure to them as much as possible. If you think you’re having a mild to moderate asthma attack ...

Here’s the research so far: Despite the fact that research hasn’t found that having mild asthma increases your risk of getting COVID-19, it’s still important for people with asthma to take ...

Learn the vital steps to take when someone experiences a severe asthma attack, from recognizing danger signs to administering ...

"Inflammation is quite complicated, but we now recognize that some patients with asthma have very mild inflammation and some have massive inflammation," Dozor clarified. In addition to ...

Among patients with mild to moderate COVID-19, the asthma drug montelukast (Singulair) did not reduce duration of symptoms, ...

By providing quick relief to individuals experiencing asthma symptoms at schools, stock inhalers prevent emergency room visits and reduce healthcare costs.

The following is a summary of "Vascular Remodeling and TSLP/Angiogenin Overexpression in Severe Mixed Asthma," published in the February 2025 issue of the Respiratory Research by Bertolini et al.